Data coverage, completeness and provenance for CHIMERIC THERAPEUTICS LIMITED in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-09-30T06:11:03. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0030 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0030 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0030 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0030 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0030 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/CHM/prices · Price parameters and adjustment semantics
Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia. The company develops CHM CDH17-directed CAR T cell therapy for the treatment of advanced colorectal cancer, gastric cancer, and intestinal neuroendocrine tumors; and CHM CLTX, a chlorotoxin-directed CAR T cell therapy to treat patients with recurrent or progressive glioblastoma and membrane-bound matrix metalloproteinase-2 (MMP2) expressing solid tumors. It also develops CHM CORE-NK for the treatment of acute myeloid leukaemia/colorectal cancer, acute myeloid cancer, blood cancer, solid tumors, MMP2 expressing solid tumors, and CDH17 expressing solid tumors. The company was incorporated in 2020 and is based in Carlton, Australia.
Website: https://www.chimerictherapeutics.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2025), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/CHM/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2025 (AUD) | 2025-06-30 | 26 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 25 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 25 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 25 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/CHM
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/CHM/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/CHM/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/CHM/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/CHM/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/CHM
Free tier — instant API key. Built for AI agents.